Wecare Probiotics Research Institute has a professional team of experts in the biotechnology industry, a leading probiotic research and development platform, and a complete quality management system. We adhere to the concept of "integrity, win-win", "responsible cooperation, professionalism, diligence, efficiency, and standardization" as the code of conduct, focusing on micro-ecology, based on general health, and developing probiotics which are suitable for Chinese people with national independent intellectual property rights. We are fully committed to the sustainable development of human health and the environment. At present, Wecare probiotics has four major probiotic research institutes in Suzhou, Wuhan, Nanjing, and Shanghai, with 4 professors (including 2 specially-appointed academicians), 3 chief scientists, and more than 100 engineers for application development. The each research institute covers nearly 1,000 square meters, with complete fermentation experimental equipment for conventional lactic acid bacteria and anaerobic lactic acid bacteria and Pilot fermentation equipment, spray drying, freeze drying equipment and other complete biological fermentation research and development equipment.
After more than two years of hard work, the R&D team isolated nearly 20,000 strains with independent property rights from nature, and uploaded the relevant strain sequences to the NCBI website. Built: WecLac® probiotic function research technology system, WecTech® probiotic technology and stability technology system, WecPro® probiotic dosage form technology system, WecCul® fermented food strains and application technology system. In 2019-2020, we set up a number of basic research and development projects for probiotic products such as the probiotic strain resource bank, Lactobacillus acidophilus, Bifidobacterium, Lactobacillus bulgaricus, Streptococcus thermophilus, Bacillus coagulans and other basic research and development projects. At present, the research and development projects are progressing smoothly. The probiotic product Bacillus coagulans has been officially put into production at the company's subsidiary Luohe factory, which has brought considerable economic benefits to the company.
